Driehaus Capital Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.27M | Sell |
376,846
-893,635
| -70% | -$12.5M | 0.04% | 300 |
|
|
2025
Q1 | $17.1M | Sell |
1,270,481
-605,395
| -32% | -$8.16M | 0.17% | 179 |
|
|
2024
Q4 | $36M | Sell |
1,875,876
-115,614
| -6% | -$2.22M | 0.3% | 111 |
|
|
2024
Q3 | $45.3M | Buy |
+1,991,490
| New | +$45.3M | 0.39% | 88 |
|
|
2023
Q3 | – | Sell |
-84,019
| Closed | -$2M | – | 450 |
|
|
2023
Q2 | $2M | Sell |
84,019
-322,758
| -79% | -$7.68M | 0.03% | 300 |
|
|
2023
Q1 | $10.3M | Sell |
406,777
-37,555
| -8% | -$955K | 0.15% | 214 |
|
|
2022
Q4 | $13M | Buy |
444,332
+107,542
| +32% | +$3.14M | 0.19% | 166 |
|
|
2022
Q3 | $6.91M | Buy |
336,790
+270,717
| +410% | +$5.55M | 0.1% | 240 |
|
|
2022
Q2 | $764K | Buy |
66,073
+16,073
| +32% | +$186K | 0.01% | 304 |
|
|
2022
Q1 | $925K | Hold |
50,000
| – | – | 0.01% | 326 |
|
|
2021
Q4 | $989K | Hold |
50,000
| – | – | 0.01% | 310 |
|
|
2021
Q3 | $823K | Buy |
+50,000
| New | +$823K | 0.01% | 326 |
|
|
2021
Q2 | – | Sell |
-33,333
| Closed | -$557K | – | 527 |
|
|
2021
Q1 | $557K | Hold |
33,333
| – | – | 0.01% | 378 |
|
|
2020
Q4 | $548K | Buy |
+33,333
| New | +$548K | 0.01% | 357 |
|